Zivanovic O

No ORCID on file · 11 papers in corpus · active 2016-2026

Study types

  • article 1
  • other 1

Condition tags

  • chronic_pelvic_pain 2
  • dysmenorrhea 1
  • endometriosis 1
other 2026
Chronic Pelvic Pain Syndrome in Women: Clinical Covariates and Comorbidity Patterns
Pain and therapy ·doi:10.1007/s40122-025-00787-7

INTRODUCTION: Chronic pelvic pain syndrome (CPPS) in women is a debilitating condition with a high prevalence (5-25%), yet its etiology remains unclear. This prospective observational study aimed to identify clinical and medical history cov…

article 2025
Cervical Tenderness (Parametropathy) is a Diagnostic Tool for the Chronic Pelvic Pain Syndrome
Pain and therapy ·doi:10.1007/s40122-025-00760-4

INTRODUCTION: Chronic pelvic pain syndrome (CPPS) is a diagnosis of exclusion in the absence of pathological findings. We aimed to test the hypothesis that cervical motion tenderness (or parametropathy) may serve as a diagnostic tool for CP…

2024
Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2024.01.015

ObjectivesMesonephric (MA) and mesonephric-like (MLA) adenocarcinomas are rare cancers, and data on clinical behavior and response to therapy are limited. We sought to report molecular features, treatment, and outcomes of MA/MLA from a sing…

2024
Update on near infrared imaging technology: indocyanine green and near infrared technology in the treatment of gynecologic cancers.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2023-004583
2023
Impact of postoperative morbidity on outcomes in patients with advanced epithelial ovarian cancer undergoing intestinal surgery at the time of primary or interval cytoreductive surgery: A Memorial Sloan Kettering Cancer Center Team Ovary study.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2023.10.013

ObjectiveTo assess the impact of short-term postoperative complications on oncologic outcomes for patients with epithelial ovarian cancer undergoing primary cytoreductive surgery (PCS) or interval cytoreductive surgery (ICS) with intestinal…

2022
Management of patients with early-stage ovarian clear cell carcinoma: risk stratification and fertility conservation.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003935

ObjectiveWe sought to describe clinicopathologic and treatment factors associated with oncologic outcomes in patients with early-stage ovarian clear cell carcinoma undergoing complete staging and in a sub-set of these patients undergoing fe…

2022
Treatment of ovarian clear cell carcinoma with immune checkpoint blockade: a case series.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1136/ijgc-2022-003430

BackgroundAlthough immune checkpoint blockade has demonstrated limited effectiveness against ovarian cancer, subset analyses from completed trials suggest possible superior efficacy in the clear cell carcinoma subtype.ObjectiveTo describe t…

2020
Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2020.07.004

ObjectiveTo evaluate the feasibility of an electronic symptom-tracking platform for patients recovering from ambulatory surgery.MethodWe assessed user response to an electronic system designed to self-report symptoms. Endpoints included com…

2017
Adjuvant chemotherapy in patients with stage I endometrioid or clear cell ovarian cancer in the platinum era: a Surveillance, Epidemiology, and End Results Cohort Study, 2000-2013.
Annals of oncology : official journal of the European Society for Medical Oncology ·doi:10.1093/annonc/mdx525

BackgroundWe sought to evaluate the impact of adjuvant chemotherapy on overall survival (OS) in patients with stage I endometrioid epithelial ovarian cancer (EEOC) or ovarian clear cell cancer (OCCC) using a national database.Patients and m…

2017
Risk-reducing salpingectomy: Let us be opportunistic.
Cancer ·doi:10.1002/cncr.30528

Because there is no screening test for ovarian cancer, effective prevention strategies may be the best way to reduce the mortality of this most lethal gynecologic malignancy. Increasing evidence supports the hypothesis that the fallopian tu…

2016
Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2016.10.016

ObjectivesWe sought to analyze the clinicopathologic features, recurrence patterns and survival outcomes of women with high-grade uterine cancer (UC) enrolled on The Gynecologic Oncology Group (GOG) LAP2 trial.MethodsThis is a post-hoc anal…